Moderna, Inc. (MRNA) Stock Overview

NASDAQ · Healthcare · Biotechnology

✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026

$145.55
Price
$58.11B
Market Cap
—
P/E Ratio
-$7.98
EPS
$176.66
52-Week High
$22.28
52-Week Low
—
Dividend Yield
USD
Currency

About Moderna, Inc.

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines…

Source: Yahoo Finance

Sector & Industry

Moderna, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.

Moderna, Inc. at a Glance

CompanyModerna, Inc.
TickerMRNA
ExchangeNASDAQ
CurrencyUSD
Price$145.55
Market cap$58.11B
P/E ratio (trailing)—
EPS (trailing)-$7.98
52-week high$176.66
52-week low$22.28
Dividend yield—
Ex-dividend date—
Beta1.11
Return on equity (ROE)-39.00%
Debt-to-equity19.04%
Average volume15.74M
Shares outstanding399.24M
SectorHealthcare
IndustryBiotechnology
Employees4,700
CountryUnited States

Investing Essentials

As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.

AMAZON The Intelligent Investor

Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.

Check Price →
AMAZON One Up On Wall Street

Peter Lynch on how everyday investors can spot winners before the professionals do.

Check Price →
AMAZON Healthcare Investing Reads

Evaluating pharma pipelines, devices and healthcare economics.

Check Price →
Disclaimer: This page is for reference only. Not financial advice. Data is a snapshot and may be out of date. Always verify with a licensed broker.

Frequently Asked Questions

What is Moderna, Inc.'s current P/E ratio?
Moderna, Inc. (MRNA) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
What is Moderna, Inc.'s market capitalisation?
Moderna, Inc.'s market cap is $58.11B based on our latest snapshot. See how it ranks by market cap →
What is MRNA's 52-week range?
Over the past 52 weeks, MRNA has traded between $22.28 and $176.66. What does the 52-week range mean? →
How volatile is Moderna, Inc. compared to the market?
Moderna, Inc. has a beta of 1.11, meaning it has historically moved more than the broader market. What does beta measure? →
Does Moderna, Inc. pay a dividend?
Moderna, Inc. does not currently pay a dividend according to our latest data.
What exchange is MRNA listed on?
MRNA is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
What sector is Moderna, Inc. in?
Moderna, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →

Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.

Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.

Recommended Reading & Tools

AMAZON Common Stocks and Uncommon Profits

Philip Fisher on what makes a business worth owning for the long term.

Check Price →
AMAZON A Random Walk Down Wall Street

Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.

Check Price →
AMAZON The Psychology of Money

Morgan Housel's short lessons on behaviour, luck and long-term wealth.

Check Price →
MRNA also appears in: S&P 500

Related Healthcare Stocks